Nancy Wysenski's Net Worth
$36.7 Million
Who is Nancy Wysenski?
Nancy Wysenski has an estimated net worth of $36.7 Million. This is based on reported shares across multiple companies, which include VERTEX PHARMACEUTICALS INC / MA, TETRAPHASE PHARMACEUTICALS INC, Provention Bio, Inc., INOVIO PHARMACEUTICALS, INC., CYTOKINETICS INC, Alkermes plc., Dova Pharmaceuticals, Inc., ENDO PHARMACEUTICALS HOLDINGS INC, NORTH AMERICAN SCIENTIFIC INC, and INDEVUS PHARMACEUTICALS INC.
SEC CIK
Nancy Wysenski's CIK is 0001294596
Past Insider Trading and Trends
2012 was Nancy Wysenski's most active year for acquiring shares with 13 total transactions. Nancy Wysenski's most active month to acquire stocks was the month of April. 2012 was Nancy Wysenski's most active year for disposing of shares, totalling 20 transactions. Nancy Wysenski's most active month to dispose stocks was the month of April. 2012 saw Nancy Wysenski paying a total of $14,203,207.17 for 447,705 shares, this is the most they've acquired in one year. In 2012 Nancy Wysenski cashed out on 912,450 shares for a total of $33,771,081.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -84.81% | -180.00K |
$64.27 | -$11,568,871.56 | 32.23K |
Scheduled
|
May 14
| ||
Form 4
|
—
|
0
|
$51.96 | -$4,434,266.80 | 32.23K |
Scheduled
|
May 14
| ||
Form 4
| -13.74% | -5.00K |
$47.59 | -$3,341,326.75 | 31.39K |
Scheduled
|
May 7 - May 8
| ||
Form 4
| +66.24% | 14.5K |
$0.01 | $145.01 | 36.39K |
Feb 2
| |||
Form 4
| -21.63% | -6.04K |
$37.00 | -$223,554.00 | 21.89K |
Scheduled
|
Jan 19
| ||
Form 4
| -15.18% | -5.00K |
$28.90 | -$144,500.00 | 27.93K |
Scheduled
|
Dec 12
| ||
Form 4
| -1.81% | -606.00 |
$29.77 | -$18,040.62 | 32.94K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
| +60.42% | 12.08K |
$0.01 | $120.84 | 32.08K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
|
∞
| 20K |
$0.01 | $200.00 | 20K |
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TETRAPHASE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Provention Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INOVIO PHARMACEUTICALS, INC. (INO) Snapshot price: $6.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CYTOKINETICS INC (CYTK) Snapshot price: $54.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.50% | 114 |
—
|
—
| 22.87K |
Jul 1
| |||
Form 4
| +32.64% | 5.6K |
—
|
—
| 22.76K |
May 15
| |||
Form 4
| +0.43% | 74 |
$84.12 | $6,224.88 | 17.16K |
Jan 2
| |||
Form 4
| +1.33% | 224 |
$27.88 | $6,245.12 | 17.08K |
Oct 2
| |||
Form 4
| +1.12% | 187 |
$33.36 | $6,238.32 | 16.86K |
Jul 3
| |||
Form 4
| +42.84% | 5K |
—
|
—
| 16.67K |
May 10
| |||
Form 4
| +1.29% | 149 |
$37.71 | $5,618.79 | 11.67K |
Apr 3
| |||
Form 4
| +1.11% | 126 |
$44.35 | $5,588.10 | 11.52K |
Jan 3
| |||
Form 4
| +0.97% | 110 |
$51.11 | $5,622.10 | 11.4K |
Oct 3
| |||
Form 4
| +1.23% | 137 |
$41.00 | $5,617.00 | 11.29K |
Jul 1
| |||
Form 4
| +81.31% | 5K |
—
|
—
| 11.15K |
May 10
| |||
Form 4
| +2.43% | 146 |
$38.38 | $5,603.48 | 6.15K |
Apr 1
| |||
Form 4
| +2.07% | 122 |
$46.00 | $5,612.00 | 6K |
Jan 3
| |||
Form 4
| +2.67% | 153 |
$36.74 | $5,621.22 | 5.88K |
Oct 1
| |||
Form 4
| +0.54% | 31 |
$19.77 | $612.87 | 5.73K |
Jul 7
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +4.36% | 238 |
$20.98 | $4,993.24 | 5.7K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1,089.32% | 5K |
—
|
—
| 5.46K |
May 12
| |||
Form 4
| +80.00% | 204 |
$24.44 | $4,985.76 | 459 |
Apr 1
| |||
Form 4
|
∞
| 255 |
$19.56 | $4,987.80 | 255 |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||